Effect of Honey For CIN II

NCT06219018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia-II
High Risk Human Papillomavirus

Interventions

DRUG: Medical grade honey formulation (MGH) (L-Mesitran®)

Sponsor

Zuyderland Medisch Centrum